According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -4,49ย โฌ. In 2022 the company made an earnings per share (EPS) of -3,72ย โฌ an increase over its 2021 EPS that were of -6,99ย โฌ.